KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other Non-Current Assets: 2009-2025

Historic Other Non-Current Assets for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Sep 2025 value amounting to $1.2 million.

  • Rigel Pharmaceuticals' Other Non-Current Assets fell 75.49% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 75.49%. This contributed to the annual value of $1.4 million for FY2024, which is 53.03% down from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Other Non-Current Assets is $1.2 million, which was down 72.11% from $4.2 million recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Other Non-Current Assets peaked at $5.0 million during Q3 2023, and registered a low of $403,000 during Q2 2022.
  • Its 3-year average for Other Non-Current Assets is $2.8 million, with a median of $3.1 million in 2023.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 923.97% in 2023, then crashed by 75.49% in 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $974,000 in 2021, then tumbled by 34.29% to $640,000 in 2022, then skyrocketed by 377.34% to $3.1 million in 2023, then crashed by 53.03% to $1.4 million in 2024, then crashed by 75.49% to $1.2 million in 2025.
  • Its Other Non-Current Assets was $1.2 million in Q3 2025, compared to $4.2 million in Q2 2025 and $1.5 million in Q1 2025.